Aged wild-type littermates and APPswe+PS1/ΔE9 mice present similar deficits in associative learning and spatial memory independent of amyloid load

Genes and Genomics

Volumn 32, Issue 1, 2010, Pages 63-70

  Paik, Soo Won ^a   Ko, Hyoung Gon ^a   Lee, Nuiibalhae ^a   Lee, Hye Ryeon ^a   Rim, Young Soo ^a   Kim, Hyoung ^a   Lee, Kyungmin ^b   Kaang, Bong Kiun ^a  

^a Seoul National University   (South Korea)

^b Kyungpook National University School of Medicine   (South Korea)

Author keywords

Alzheimer's disease; A plaque; Learning; Spatial memory

Indexed keywords

MUS; MUS MUSCULUS;

EID: 77955171705     PISSN: 19769571     EISSN: 20929293     Source Type: Journal    
DOI: 10.1007/s13258-010-0833-8     Document Type: Article

References (44)

1. Arendash GW, King DL, Gordon MN, Morgan D, Hatcher JM, Hope CE and Diamond DM (2001) Progressive, age-related behavioral impairments in transgenic mice carrying both mutant amyloid precursor protein and presenilin-1 transgenes. Brain Res. 891: 42-53.
2. Belzung C and Griebel G (2001) Measuring normal and pathological anxiety-like behaviour in mice: a review. Behav. Brain Res. 125: 141-149.
3. Bertholet JY and Crusio WE (1991) Spatial and non-spatial spontaneous alternation and hippocampal mossy fibre distribution in nine inbred mouse strains. Behav. Brain Res. 43: 197-202.
4. Brandeis R, Brandys Y and Yehuda S (1989) The use of the Morris Water Maze in the study of memory and learning. Int. J. Neurosci. 48: 29-69.
5. Buckner RL (2004) Memory and executive function in aging and AD: multiple factors that cause decline and reserve factors that compensate. Neuron 44: 195-208.
6. Buttini M, Yu GQ, Shockley K, Huang Y, Jones B, Masliah E, Mallory M, Yeo T, Longo FM and Mucke L (2002) Modulation of Alzheimer-like synaptic and cholinergic deficits in transgenic mice by human apolipoprotein E depends on isoform, aging, and overexpression of amyloid beta peptides but not on plaque formation. J. Neurosci. 22: 10539-10548.
7. Chang EH, Savage MJ, Flood DG, Thomas JM, Levy RB, Mahadomrongkul V, Shirao T, Aoki C and Huerta PT (2006) AMPA receptor downscaling at the onset of Alzheimer's disease pathology in double knockin mice. Proc. Natl. Acad. Sci. USA 103: 3410-3415.
8. Dickey CA, Loring JF, Montgomery J, Gordon MN, Eastman PS and Morgan D (2003) Selectively reduced expression of synaptic plasticity-related genes in amyloid precursor protein + presenilin-1 transgenic mice. J. Neurosci. 23: 5219-5226.
9. Duff K, Eckman C, Zehr C, Yu X, Prada CM, Pereztur J, Hutton M, Buee L, Harigaya Y, Yager D, et al. (1996) Increased amy-loid-beta42(43) in brains of mice expressing mutant presenilin 1. Nature 383: 710-713.
10. Gilpin H, Whitcomb D and Cho K (2008) Atypical evening cortisol profile induces visual recognition memory deficit in healthy human subjects. Mol. Brain 1: 4.
11. Grauer E and Kapon Y (1993) Wistar-Kyoto rats in the Morris water maze: impaired working memory and hyper-reactivity to stress. Behav. Brain Res. 59: 147-151.
12. Gruart A, Lopez-Ramos JC, Munoz MD and Delgado-Garcia JM (2008) Aged wild-type and APP, PS1, and APP + PS1 mice present similar deficits in associative learning and synaptic plasticity independent of amyloid load. Neurobiol. Dis. 30: 439-450.
13. Haxby JV, Raffaele K, Gillette J, Schapiro MB and Rapoport SI (1992) Individual trajectories of cognitive decline in patients with dementia of the Alzheimer type. J. Clin. Exp. Neuropsychol. 14: 575-592.
14. Holcomb L, Gordon MN, McGowan E, Yu X, Benkovic S, Jantzen P, Wright K, Saad I, Mueller R, Morgan D, et al. (1998) Accelerated Alzheimer-type phenotype in transgenic micecarrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat. Med. 4: 97-100.
15. Holcomb LA, Gordon MN, Jantzen P, Hsiao K, Duff K and Morgan D (1999) Behavioral changes in transgenic mice expressing both amyloid precursor protein and presenilin-1 mutations: lack of association with amyloid deposits. Behav. Genet. 29: 177-185.
16. Hollingworth P, Hamshere ML, Moskvina V, Dowzell K, Moore PJ, Foy C, Archer N, Lynch A, Lovestone S, Brayne C, et al. (2006) Four components describe behavioral symptoms in 1,120 individuals with late-onset Alzheimer's disease. J. Am. Geriatr. Soc. 54: 1348-1354.
17. Holscher C (1999) Stress impairs performance in spatial water maze learning tasks. Behav. Brain Res. 100: 225-235.
18. Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, Yang F and Cole G (1996) Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274: m99-102.
19. Jacobsen JS, Wu CC, Redwine JM, Comery TA, Arias R, Bowlby M, Martone R, Morrison JH, Pangalos MN, Reinhart PH, et al. (2006) Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. USA 103: 5161-5166.
20. Jankowsky JL, Fadale DJ, Anderson J, Xu GM, Gonzales V, Jenkins NA, Copeland NG, Lee MK, Younkin LH, Wagner SL, et al. (2004) Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum. Mol. Genet. 13: 159-170.
21. Jankowsky JL, Melnikova T, Fadale DJ, Xu GM, Slunt HH, Gonzales V, Younkin LH, Younkin SG, Borchelt DR and Savonenko AV (2005) Environmental enrichment mitigates cognitive deficits in a mouse model of Alzheimer's disease. J. Neurosci. 25: 5217-5224.
22. Kelly PH, Bondolfi L, Hunziker D, Schlecht HP, Carver K, Maguire E, Abramowski D, Wiederhold KH, Sturchler-Pierrat C, Jucker M, et al. (2003) Progressive age-related impairment of cognitive behavior in APP23 transgenic mice. Neurobiol. Aging 24: 365-378.
23. Kim J, Lee S, Park K, Hong I, Song B, Son G, Park H, Kim WR, Park E, Choe HK, et al. (2007) Amygdala depotentiation and fear extinction. Proc. Natl. Acad. Sci. USA 104: 20955-20960.
24. Kim JJ and Fanselow MS (1992) Modality-specific retrograde amnesia of fear. Science 256: 675-677.
25. King DL and Arendash GW (2002) Behavioral characterization of the Tg2576 transgenic model of Alzheimer's disease through 19 months. Physiol. Behav. 75: 627-642.
26. Lalonde R, Kim HD and Fukuchi K (2004) Exploratory activity, anxiety, and motor coordination in bigenic APPswe+PS1/Delta;E9 mice. Neurosci. Lett. 369: 156-161.
27. Lalonde R, Lewis TL, Strazielle C, Kim H and Fukuchi K (2003) Transgenic mice expressing the betaAPP695SWE mutation: effects on exploratory activity, anxiety, and motor coordination. Brain Res. 977: 38-45. (Pubitemid 36638692)
28. Lee Y, Chang DJ, Lee YS, Chang KA, Kim H, Yoon JS, Lee S, Suh YH and Kaang BK (2003) Beta-amyloid peptide binding protein does not couple to G protein in a heterologous Xenopus expression system. J. Neurosci. Res. 73: 255-259.
29. Levy-Lahad E, Wasco W, Poorkaj P, Romano DM, Oshima J,Pettingell WH, Yu CE, Jondro PD, Schmidt SD, Wang K and et al. (1995) Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 269: 973-977.
30. Liu L, Orozco IJ, Planel E, Wen Y, Bretteville A, Krishnamurthy P, Wang L, Herman M,Figueroa H, Yu WH, et al. (2008) A transgenic rat that develops Alzheimer's disease-like amyloid pathology, deficits in synaptic plasticity and cognitive impairment. Neurobiol. Dis. 31: 46-57.
31. Morris R (1984) Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 11: 47-60.
32. Nilsson LN, Bales KR, Di Carlo G, Gordon MN, Morgan D, Paul SM and Potter H (2001) Alpha-1-antichymotrypsin promotes beta-sheet amyloid plaque deposition in a transgenic mouse model of Alzheimer's disease. J. Neurosci. 21: 1444-1451.
33. Prut L and Belzung C (2003) The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur. J. Pharmacol. 463: 3-33.
34. Rapp PR and Amaral DG (1992) Individual differences in the cognitive and neurobiological consequences of normal aging. Trends Neurosci 15: 340-345.
35. Roberson ED, Scearce-Levie K, Palop JJ, Yan F, Cheng IH, Wu T, Gerstein H, Yu GQ and Mucke L (2007) Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model. Science 316: 750-754.
36. Rogaev EI, Sherrington R, Rogaeva EA, Levesque G, Ikeda M, Liang Y, Chi H, Lin C, Holman K, Tsuda T, et al. (1995) Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 376: 775-778.
37. Sarter M, Bodewitz G and Stephens DN (1988) Attenuation of scopol-amine-induced impairment of spontaneous alteration behaviour by antagonist but not inverse agonist and agonist beta-carbolines. Psychopharmacology (Berl) 94: 491-495.
38. Saura CA, Chen G, Malkani S, Choi SY, Takahashi RH, Zhang D, Gouras GK, Kirkwood A, Morris RG and Shen J (2005) Conditional inactivation of presenilin 1 prevents amyloid accumulation and temporarily rescues contextual and spatial working memory impairments in amyloid precursor protein transgenic mice. J. Neurosci. 25: 6755-6764.
39. Savonenko AV, Xu GM, Price DL, Borchelt DR and Markowska AL (2003) Normal cognitive behavior in two distinct congenic lines of transgenic mice hyperexpressing mutant APP SWE. Neurobiol. Dis. 12: 194-211.
40. Terry RD and Katzman R (1983) Senile dementia of the Alzheimer type. Ann. Neurol. 14: 497-506.
41. Wang SH, Teixeira CM, Wheeler AL and Frankland PW (2009) The precision of remote context memories does not require the hippocampus. Nat. Neurosci. 12: 253-255.
42. Wenk GL (2004) Assessment of spatial memory using the radial arm maze and Morris water maze. Curr. Protoc. Neurosci. Chapter 8: Unit 85A.
43. Whitehouse PJ, Price DL, Clark AW, Coyle JT and DeLong MR (1981) Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann. Neurol. 10: 122-126.
44. Wong TP, Debeir T, Duff K and Cuello AC (1999) Reorganizationof cholinergic terminals in the cerebral cortex and hippocampus in transgenic mice carrying mutated presenilin-1 and amyloid pre-cursor protein transgenes. J. Neurosci. 19: 2706-2716.